Overview

Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail

Status:
Completed
Trial end date:
2013-02-20
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Pharmaceutical Solutions
Tavaborole
Criteria
Inclusion Criteria:

- Clinical diagnosis of distal subungual onychomycosis affecting at least one great
toenail

- KOH positive at screening

- Willingness not to use any other products including nail polish applied to the
toenails during the study

- Women of childbearing potential who are currently sexually active must agree to use
contraception for the entire study period

Exclusion Criteria:

- Concurrent or recent use of certain topical or systemic medications without a
sufficient washout period

- History of any significant chronic fungal disease other than onychomycosis

- Significant confounding conditions as assessed by study doctor

- Participated in any other trial of an investigational drug or device within 30 days or
participation in a research study concurrent with this study

- Pregnancy or lactation